Spatiotemporal Regulation of Membrane Raft Trafficking in Virus Activated Cells
病毒激活细胞膜筏运输的时空调控
基本信息
- 批准号:8204961
- 负责人:
- 金额:$ 7.55万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-12-15 至 2012-11-30
- 项目状态:已结题
- 来源:
- 关键词:ActinsAcuteAdhesionsAffinityAmericanBerylliumBindingBiochemicalBiological AssayBiological ModelsCD55 AntigensCardiopulmonaryCell surfaceCellsCellular biologyClathrinCollaborationsDevelopmentDiseaseDissectionDoseEndocytosisEventFDA approvedFluorescent ProbesFocal AdhesionsGPI Membrane AnchorsGlycoproteinsHantavirusHemorrhagic Fever with Renal SyndromeInfectionIntegrinsLabelLaboratoriesLeadLifeLinkLipidsMeasurementMediatingMediationMembraneMembrane MicrodomainsMethodsMicroscopyMolecularMonitorMovementOrganellesPathogenesisPathway interactionsPatternPharmaceutical PreparationsPositioning AttributeProteinsReagentRecruitment ActivityRegulationResearchRodentRouteScienceSignal TransductionSin Nombre virusSiteSyndromeSystemTechnologyTestingTimeTitrationsTranslatingUltraviolet RaysVaccinesViralVirionVirusVirus DiseasesVirus ReceptorsWorkbasebiosafety level 2 facilitycrosslinkexperiencehigh throughput screeninghuman diseaseinhibitor/antagonistinnovationkillingsnovel strategiesobligate intracellular parasiteparticlepolarized cellpositional cloningpreventprogramspublic health relevancereceptorresearch studysmall moleculespatiotemporaltooltraffickinguptakeviral RNAvirology
项目摘要
DESCRIPTION (provided by applicant): Hantaviruses can cause two often-severe diseases of humans: hemorrhagic fever with renal syndrome or hantavirus cardiopulmonary syndrome (HCPS). The lack of vaccines or specific drugs to prevent or treat HCPS disease, and the requirement for conducting experiments in a biosafety level 3 laboratory (BSL-3), have limited the ability to effectively probe the mechanism of infection and disease pathogenesis. We have therefore initiated a program to study Sin Nombre virus (SNV) killed with a calibrated dose of UV radiation as a model system to dissect its mechanism of cellular entry in BSL-2 facilities. As obligate intracellular parasites, hantaviruses depend on cellular mechanisms for entry and release from their host cells. Membrane rafts on the cell surface are often the originating point of cell signaling, adhesion and endocytosis. Viruses use signaling elements that are bundled in membrane rafts and co-opt the cellular endocytic machinery to achieve entry and productive infection. However, mechanistic dissection of virus entry has been hampered because glycoproteins of many hantaviruses are difficult to express and no tractable reverse genetics system is available. Therefore, new approaches to understanding the mechanistic steps of infection are needed and critical to the identification of targets for blocking infection. We demonstrated that UV-killed SNV attaches to the glycosylphosphatidylinositol (GPI)-anchored protein decay accelerating factor (DAF/CD55) and low affinity state ???3 integrins in a manner that parallels the results obtained from infectivity assays using live virions. Therefore, we were able to monitor virus uptake in real time and show that the initial binding of SNV to DAF is followed by Rac1 stimulated actin remodeling, disassembly of focal adhesions, and leads to loss of cell-cell contact and cell-substrate adhesion. Our observations are significant because they offer the first temporal and spatial dissection of the events involved in hantavirus entry and offer a plausible mechanistic explanation for the acute cardiopulmonary syndrome caused by virus infection. To test this hypothesis we will pursue the following aims. Aim 1: To define the spatiotemporal redistribution of cognate receptors (DAF/CD55 and ???3 integrins) following hantavirus binding. Aim 2: To define the mechanism of hantavirus endocytosis and its relationship to ???3 and DAF.
PUBLIC HEALTH RELEVANCE: Hantavirus cardiopulmonary syndrome is a progressive and often fatal form of human disease caused by Sin Nombre Virus (SNV), which is a rodent virus endemic to the American Southwest. This proposal brings together a unique team employing tools and concepts of biophysical science, molecular cell biology and virology to study the mechanism used by hantaviruses to enter cells. We are able to use state of the art tools to examine how viruses hijack the cellular machinery of endocytosis to enter and infect cells through the mediation of specialized membrane microdomains called lipid rafts. The long-term result of this work could be used to determine route of entry for anti-viral treatment.
描述(申请人提供):汉坦病毒可引起人类两种常见的严重疾病:肾综合征出血热或汉坦病毒心肺综合征(HCPS)。缺乏预防或治疗HCPS疾病的疫苗或特效药,以及需要在生物安全三级实验室(BSL-3)进行实验,限制了有效探索感染机制和疾病发病机制的能力。因此,我们已经启动了一项计划,以研究用校准剂量的UV辐射杀死的Sin Nombre病毒(SNV)作为模型系统,以剖析其在BSL-2设施中进入细胞的机制。作为专性细胞内寄生虫,汉坦病毒依赖于细胞机制进入和从其宿主细胞释放。细胞表面的膜筏通常是细胞信号传导、粘附和内吞的起点。病毒使用捆绑在膜筏中的信号元件,并协同细胞内吞机制来实现进入和生产性感染。然而,由于许多汉坦病毒的糖蛋白难以表达,并且没有可利用的反向遗传学系统,因此病毒进入的机械解剖受到阻碍。因此,需要新的方法来理解感染的机制步骤,并且对于确定阻断感染的靶点至关重要。我们证明,紫外线杀死的SNV附着在糖基磷脂酰肌醇(GPI)锚定的蛋白衰变加速因子(CD 55)和低亲和力状态?3整联蛋白,其方式与使用活病毒体的感染性测定获得的结果平行。因此,我们能够监测病毒摄取在真实的时间,并表明,SNV的初始结合到Rac 1刺激肌动蛋白重塑,解体的焦点粘附,并导致细胞-细胞接触和细胞-基质粘附的损失。我们的观察是有意义的,因为他们提供了第一个时间和空间解剖的汉他病毒进入所涉及的事件,并提供了一个合理的机制解释的急性心肺综合征引起的病毒感染。为了检验这个假设,我们将追求以下目标。目的1:确定同源受体(CD 14/CD 55和?3整联蛋白)。目的2:阐明汉坦病毒内吞作用的机制及其与细胞增殖的关系。3、。
公共卫生相关性:汉坦病毒心肺综合征是一种进行性的,往往是致命的人类疾病,由辛诺布尔病毒(SNV)引起,这是一种啮齿动物病毒,流行于美国西南部。这项建议汇集了一个独特的团队,采用生物物理科学,分子细胞生物学和病毒学的工具和概念来研究汉坦病毒进入细胞的机制。我们能够使用最先进的工具来研究病毒如何劫持细胞内吞机制,通过称为脂筏的专门膜微区的介导进入和感染细胞。这项工作的长期结果可用于确定抗病毒治疗的进入途径。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Small-Volume Flow Cytometry-Based Multiplex Analysis of the Activity of Small GTPases.
- DOI:10.1007/978-1-4939-8612-5_13
- 发表时间:2018
- 期刊:
- 影响因子:0
- 作者:Simons P;Bondu V;Wandinger-Ness A;Buranda T
- 通讯作者:Buranda T
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TIONE BURANDA其他文献
TIONE BURANDA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TIONE BURANDA', 18)}}的其他基金
Investigating the role and therapeutic potential of the alpha5beta1 integrin in risk factors for COVID-19-associated cognitive impairment
研究 α5β1 整合素在 COVID-19 相关认知障碍危险因素中的作用和治疗潜力
- 批准号:
10658178 - 财政年份:2023
- 资助金额:
$ 7.55万 - 项目类别:
Development of HTS Assays for Inhibitors of Viral-Cell Interactions
病毒-细胞相互作用抑制剂的 HTS 检测方法的开发
- 批准号:
8049411 - 财政年份:2010
- 资助金额:
$ 7.55万 - 项目类别:
Spatiotemporal Regulation of Membrane Raft Trafficking in Virus Activated Cells
病毒激活细胞膜筏运输的时空调控
- 批准号:
8028735 - 财政年份:2010
- 资助金额:
$ 7.55万 - 项目类别:
Membrane Organization in Cell Signaling and Adhesion
细胞信号传导和粘附中的膜组织
- 批准号:
7382599 - 财政年份:2004
- 资助金额:
$ 7.55万 - 项目类别:
Membrane Organization in Cell Signaling and Adhesion
细胞信号传导和粘附中的膜组织
- 批准号:
6866410 - 财政年份:2004
- 资助金额:
$ 7.55万 - 项目类别:
Membrane Organization in Cell Signaling and Adhesion
细胞信号传导和粘附中的膜组织
- 批准号:
7194318 - 财政年份:2004
- 资助金额:
$ 7.55万 - 项目类别:
Membrane Organization in Cell Signaling and Adhesion
细胞信号传导和粘附中的膜组织
- 批准号:
6769778 - 财政年份:2004
- 资助金额:
$ 7.55万 - 项目类别:
Membrane Organization in Cell Signaling and Adhesion
细胞信号传导和粘附中的膜组织
- 批准号:
7015037 - 财政年份:2004
- 资助金额:
$ 7.55万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 7.55万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 7.55万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 7.55万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 7.55万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 7.55万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 7.55万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 7.55万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 7.55万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 7.55万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 7.55万 - 项目类别:
Standard Grant